These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 14576143)
1. Simulation of human gentamicin pharmacokinetics in an experimental Enterococcus faecalis endocarditis model. Dubé L; Caillon J; Gras-Le Guen C; Jacqueline C; Kergueris MF; Granry JC; Potel G; Bugnon D Antimicrob Agents Chemother; 2003 Nov; 47(11):3663-6. PubMed ID: 14576143 [TBL] [Abstract][Full Text] [Related]
2. Treatment of experimental endocarditis due to Enterococcus faecalis using once-daily dosing regimen of gentamicin plus simulated profiles of ampicillin in human serum. Gavaldà J; Cardona PJ; Almirante B; Capdevila JA; Laguarda M; Pou L; Crespo E; Pigrau C; Pahissa A Antimicrob Agents Chemother; 1996 Jan; 40(1):173-8. PubMed ID: 8787901 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides. Gavaldá J; Onrubia PL; Gómez MT; Gomis X; Ramírez JL; Len O; Rodríguez D; Crespo M; Ruíz I; Pahissa A J Antimicrob Chemother; 2003 Sep; 52(3):514-7. PubMed ID: 12917251 [TBL] [Abstract][Full Text] [Related]
4. Gentamicin once-daily in enterococcal endocarditis. Bassetti M; Righi E; Crapis M; Cojutti P; Venturini S; Viale P; Pea F Int J Cardiol; 2013 Oct; 168(5):5033-4. PubMed ID: 23931973 [No Abstract] [Full Text] [Related]
5. Bactericidal activity of gentamicin against Enterococcus faecalis in vitro and in vivo. Lefort A; Arthur M; Garry L; Carbon C; Courvalin P; Fantin B Antimicrob Agents Chemother; 2000 Aug; 44(8):2077-80. PubMed ID: 10898678 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of ampicillin plus arbekacin in experimental rabbit endocarditis caused by an Enterococcus faecalis strain with high-level gentamicin resistance. Kak V; Donabedian SM; Zervos MJ; Kariyama R; Kumon H; Chow JW Antimicrob Agents Chemother; 2000 Sep; 44(9):2545-6. PubMed ID: 10952613 [TBL] [Abstract][Full Text] [Related]
7. Teicoplanin versus vancomycin for prophylaxis of experimental Enterococcus faecalis endocarditis in rats. Entenza JM; Calandra T; Moosmann Y; Malinverni R; Glauser MP Antimicrob Agents Chemother; 1992 Jun; 36(6):1256-62. PubMed ID: 1416824 [TBL] [Abstract][Full Text] [Related]
8. Which trial do we need? Aminopenicillin-gentamicin versus aminopenicillin-ceftriaxone for Enterococcus faecalis endocarditis. Luque-Paz D; Cuervo G; Miró JM; Tattevin P Clin Microbiol Infect; 2023 Jun; 29(6):676-678. PubMed ID: 36889644 [No Abstract] [Full Text] [Related]
9. Efficacy of teicoplanin-gentamicin given once a day on the basis of pharmacokinetics in humans for treatment of enterococcal experimental endocarditis. López P; Gavaldà J; Martin MT; Almirante B; Gomis X; Azuaje C; Borrell N; Pou L; Falcó V; Pigrau C; Pahissa A Antimicrob Agents Chemother; 2001 May; 45(5):1387-93. PubMed ID: 11302800 [TBL] [Abstract][Full Text] [Related]
10. The optimal aminoglycoside and its dosage for the treatment of severe Enterococcus faecalis infection. An experimental study in the rabbit endocarditis model. Dubé L; Caillon J; Jacqueline C; Bugnon D; Potel G; Asseray N Eur J Clin Microbiol Infect Dis; 2012 Oct; 31(10):2545-7. PubMed ID: 22395262 [TBL] [Abstract][Full Text] [Related]
12. Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci. Ramos MC; Grayson ML; Eliopoulos GM; Bayer AS Antimicrob Agents Chemother; 1992 Sep; 36(9):1864-9. PubMed ID: 1329632 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of tigecycline alone and in combination with gentamicin in the treatment of experimental endocarditis due to linezolid-resistant Enterococcus faecium. Pontikis K; Pefanis A; Tsaganos T; Tzepi IM; Carrer DP; Giamarellou H Antimicrob Agents Chemother; 2013 Jul; 57(7):3392-4. PubMed ID: 23587961 [TBL] [Abstract][Full Text] [Related]
14. Antibiotic resistance among enterococci causing endocarditis in the UK: analysis of isolates referred to a reference laboratory. Johnson AP; Warner M; Woodford N; Speller DC; Livermore DM BMJ; 1998 Sep; 317(7159):629-30. PubMed ID: 9727989 [No Abstract] [Full Text] [Related]
15. Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis. Lavoie SR; Wong ES; Coudron PE; Williams DS; Markowitz SM Antimicrob Agents Chemother; 1993 Jul; 37(7):1447-51. PubMed ID: 8363374 [TBL] [Abstract][Full Text] [Related]
16. Consequences of VanE-type resistance on efficacy of glycopeptides in vitro and in experimental endocarditis due to Enterococcus faecalis. Lafaurie M; Perichon B; Lefort A; Carbon C; Courvalin P; Fantin B Antimicrob Agents Chemother; 2001 Oct; 45(10):2826-30. PubMed ID: 11557476 [TBL] [Abstract][Full Text] [Related]
17. Once-daily aminoglycoside in the treatment of Enterococcus faecalis endocarditis: case report and review. Tam VH; Mckinnon PS; Levine DP; Brandel SM; Rybak MJ Pharmacotherapy; 2000 Sep; 20(9):1116-9. PubMed ID: 10999505 [TBL] [Abstract][Full Text] [Related]
18. Two-step acquisition of resistance to the teicoplanin-gentamicin combination by VanB-type Enterococcus faecalis in vitro and in experimental endocarditis. Lefort A; Baptista M; Fantin B; Depardieu F; Arthur M; Carbon C; Courvalin P Antimicrob Agents Chemother; 1999 Mar; 43(3):476-82. PubMed ID: 10049254 [TBL] [Abstract][Full Text] [Related]
19. Endocarditis due to high-level gentamicin-resistant Enterococcus faecalis. Lee PY; Das SS Postgrad Med J; 1995 Feb; 71(832):117-9. PubMed ID: 7724425 [TBL] [Abstract][Full Text] [Related]